2019 Novel Coronavirus: A Review on Epidemiology, Pathophysiology, Diagnosis and Current Clinical Trials in Vaccine Development

Author(s): Megala Jayaraman*, Sabari Krishna B. B., Parijat Dutta, Jayesh Telang, Sreshta Adhikari, Arpan Neeraj Pardeshi

Journal Name: Coronaviruses
The World's First International Journal Dedicated to Coronaviruses

Volume 2 , Issue 8 , 2021

Article ID: e260721189629
Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Coronavirus disease-2019, a viral disease caused by the novel severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), was identified by the Centre for Disease Control (CDC), China, on January 7, 2020. This mysterious respiratory epidemic occurred in Wuhan, China, in late December 2019. A month after its outbreak in China, the World Health Organization (WHO) declared it as a public health emergency of international concern (PHEIC) due to its severity and high transmission potential throughout the world, leading many nations to implement multiple lockdown sessions and strict social distancing measures. As of September 21, 2020, 30,675,675 active cases and 954,417 deaths had been reported worldwide. Intensive research is being carried out across the globe to identify precise diagnostic techniques and develop novel, effective vaccines against the virus. Herein, we elaborate on details of epidemiology, genetics, pathophysiology, diagnosis, prevention, and vaccine trials related to this pandemic.

Keywords: COVID-19, global outbreak, novel coronavirus, pathogenesis, SARS-CoV-2, vaccines.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 29 December, 2020
Article ID: e260721189629
Pages: 13
DOI: 10.2174/2666796701666201230104321

Article Metrics

PDF: 18